- US12582647utility2026Systems and Methods for Treating an Opioid-induced Adverse Pharmacodynamic Response0 cites
- US12377076utility2025Compounds for Treating Lymphoma or a T-cell Malignant Disease0 cites
- US12370178utility2025Tinostamustine for Use in the Treatment of T-cell Prolymphocytic Leukaemia0 cites
- US12370191utility2025Treatment and Prevention of Sleep Disorders0 cites
- US12371427utility2025Polymorphic Forms of a Substituted-quinoxaline-type Bridged-piperidine Compound0 cites
- US12303492utility2025Compounds for Treating TNBC0 cites
- US12297199utility2025Morphinan Derivatives and Use Thereof0 cites
- US12257237utility2025Tinostamustine for Use in Treating Sarcoma0 cites
- US12201629utility2025Method of Treatment and Dosage Forms Thereof0 cites
- US12171762utility2024Sleep Disorder Treatment and Prevention0 cites
- US12161754utility2024Abuse Deterrent Morphine Sulfate Dosage Forms0 cites
- US12053464utility2024Pharmaceutical Dosage Forms0 cites
- US11918558utility2024Tinostamustine for Use in the Treatment of T-cell Prolymphocytic Leukaemia0 cites
- US11911510utility2024Pharmaceutical Dosage Forms0 cites
- US11911512utility2024Encased Tamper Resistant Controlled Release Dosage Forms0 cites
- US11896583utility2024Tinostamustine for Use in Treating Ovarian Cancer0 cites
- US11896722utility2024Methods and Compositions Particularly for Treatment of Attention Deficit Disorder0 cites
- US11865112utility2024Compositions and Methods for Opioid Antagonist Delivery0 cites
- US11857547utility2024Compositions and Methods for Opioid Antagonist Delivery0 cites
- US11834447utility2023Indole Derivatives and Use Thereof0 cites
Page 1 of 2Next →